Security key
640671400
NEPHROS INC - Common stock, par value $0.001 per share (NEPH)
CUSIP: 640671400
Q4 2020 13F Holders as of 31 Dec 2020
- Security type / class
- Equity / Common stock, par value $0.001 per share
- Total 13F shares
- 5,282,295
- Total 13F value
- $45,322,000
- Share change
- +257,576
- SEC-reported price per share
- $8.58
- Number of holders
- 14
- Value change
- +$2,352,286
- Number of buys
- 7
- Number of sells
- 7
- Shares outstanding
- 10,851,408
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2020
Institutions
14
Top holders
10
NEPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
NEPHROS INC SEC filings
NEPHROS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640671400
Recent filing periods:
Ownership snapshot
Top reported holders of NEPH - NEPHROS INC - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
WEXFORD CAPITAL LP
Disclosed value leader
WEXFORD CAPITAL LP
Comparable rows
0/15
Latest evidence
30 Sep 2020
13F
Highest disclosed value: $24,550,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
WEXFORD CAPITAL LP has the largest disclosed position value at $24.55M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens WEXFORD CAPITAL LP's linked filing trail.
Disclosed position value
Top 5
WEXFORD CAPITAL LP
$24.55M
Cowen Prime Services LLC
$2.23M
Parkman Healthcare Partners LLC
$1.74M
BARD ASSOCIATES INC
$1.46M
Overbrook Management Corp
$659K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| WEXFORD CAPITAL LP |
13F
Company
|
—
denominator unverified
|
$24,550,000
3,395,579 shares
|
— | 30 Sep 2020 |
| Cowen Prime Services LLC |
13F
Company
|
—
denominator unverified
|
$2,234,000
309,009 shares
|
— | 30 Sep 2020 |
| Parkman Healthcare Partners LLC |
13F
Company
|
—
denominator unverified
|
$1,745,000
241,411 shares
|
— | 30 Sep 2020 |
| BARD ASSOCIATES INC |
13F
Company
|
—
denominator unverified
|
$1,459,000
201,798 shares
|
— | 30 Sep 2020 |
| Overbrook Management Corp |
13F
Company
|
—
denominator unverified
|
$659,000
91,145 shares
|
— | 30 Sep 2020 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$410,000
56,737 shares
|
— | 30 Sep 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
14
Shares
5,282,295
Rows available
14
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2020 vs Q2 2026 Across Filers
Q2 2026 holders
33
Q4 2020 holders
14
Holder diff
-19
| Investor | Q2 2026 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q2 2026 value | Q4 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend